… the dengue vaccine pipelines as well as exploring challenges in dengue vaccine development.
… The characteristics, efficacies and limitations of each dengue vaccine will be discussed …

… to develop dengue vaccines and an overview of different classes of dengue vaccine candidates
… A discussion on therapeutic anti-dengue antibodies and the use of DENV as a vaccine …

… Factors that contribute to protection from and risk of dengue and severe dengue disease …
Results from Phase 3 vaccine efficacy trials have recently become available for one vaccine …

… a licensed dengue vaccine is not yet available, the scope and intensity of dengue vaccine
… The uniqueness of the dengue viruses and the spectrum of disease resulting from infection …

… the dengue vaccine pipelines as well as exploring challenges in dengue vaccine development.
… The characteristics, efficacies and limitations of each dengue vaccine will be discussed …

… While no licensed dengue vaccine currently exists, vaccine … dengue vaccine candidates in
preclinical development. It is based on published and unpublished data presented by vaccine …

… To avoid ADE of DENV infection, a dengue vaccine is expected to be tetravalent, conferring
… challenge to dengue vaccine development. Most current vaccine candidates seem to elicit …

… vaccines, and DNA vaccines [90]. In addition to the usual concerns of safety and immunogenicity,
dengue vaccines … risks worsening the effect of dengue infection through immunologic …

… of the dengue outbreak would increase. The development of a dengue vaccine has been in
… Prior to 1952, a vaccine had been developed from DEN2, cultured in rat brains, but it was …

… of dengue vaccine clinical trials. In the light of recent progress made in our understanding
of dengue pathogenesis and immune correlates of protection, novel vaccine strategies have …